ARANESP
ARANESP
Approved
DIN Number
02246359
Drug Class
Human
Market Date
N/A
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02246359
AIG Number0148081007
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
B03XA02 DARBEPOETIN ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
,
Subcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DARBEPOETIN ALFAActive
Strength: 325 MCG / ML
Monograph: DARBEPOETIN ALFA